Chief of Urology, University of Utah
University of Utah
Dr. Jeremy Myers completed his urology training at University of Colorado with a fellowship in trauma and reconstructive urology at the San Francisco General Hospital. He is currently a professor at the University of Utah School of Medicine, Department of Surgery (urology). He also serves as Chief of Urology for University of Utah. He is on the board of directors and the secretary of the Society of Genitourinary Reconstructive Surgeons. Dr. Myers is the director of the University of Utah's clinical fellowship in Genitourinary Injury and Reconstructive Urology.
Dr. Myers has been very active in academic urology. His research focuses on three aspects of benign urologic disease: neurogenic bladder, reconstructive surgery, and management of urologic trauma. He was primary investigator of a Patient Centered Outcomes Research Institute (PCORI) sponsored project entitled "Bladder Management and Spinal Cord Injury". In addition, also involving neurogenic bladder research, he is primary investigator of a Department of Defense grant entitled "Sacral Neuromodulation in Acute Spinal Cord Injury". These studies involve the Neurogenic Bladder Research Group (NBRG), started by Dr. Myers and several other investigators. NBRG is a large multi-institutional group focused upon patient reported outcomes and robust clinical studies. In addition, Dr. Myers is a founding member of the Trauma and Urologic Research Network of Surgeons (TURNS), another multi-institutional group of 14 centers in North America, studying reconstructive urology. His work in urotrauma has involved the American Association for the Surgery of Trauma (AAST). He is the primary investigator for two prospective trials through the AAST, which involve greater than 20 level-1 trauma centers in the United States. These trials are focused on current management of renal and bladder trauma, as well as the outcomes of urethral realignment after pelvic fracture urethral injury.
Disclosure information not submitted.
Friday, April 28, 2023
10:41 AM – 11:10 AM CST